Epilepsy :: FDA approves first generic anticonvulsant drug Trileptal
Health is a unity and harmony within the mind, body and spirit which is unique to each person, and is as defined by that person. The level of wellness or health is, in part, determined by the ability to deal with and defend against stress. Health is determined by physiological, psychological, socio-cultural, spiritual, and developmental stage variables.
logo - spiritindia - Epilepsy :: FDA approves first generic anticonvulsant drug Trileptal

FDA approves first generic anticonvulsant drug Trileptal

Epilepsy :: FDA approves first generic anticonvulsant drug Trileptal

Epilepsy :: FDA approves first generic anticonvulsant drug Trileptal

The U.S. Food and Drug Administration approved the first generic versions of Trileptal (oxcarbazepine), an anticonvulsant drug. Generic oxcarbazepine is FDA-approved for use alone or in combination with other medications in the treatment of partial seizures in adults and children aged four years and above.

"FDA requires generic drugs to have the same quality, strength, purity and stability as brand-name drugs," said Gary J. Buehler, director of FDA's Office of Generic Drugs. "The agency ensures that generic drugs are safe and effective, offering alternatives to Americans in choosing their prescription drugs."

Oxcarbazepine tablets in three strengths (150 milligrams, 300 milligrams and 600 milligrams) are manufactured by Roxane Laboratories Inc., Glenmark Pharmaceuticals Limited, and Sun Pharmaceutical Industries Limited.

The labeling of the generic products may differ from that of Trileptal because parts of the Trileptal labeling are protected by patents and/or exclusivity.

According to the publication Drug Topics, Trileptal was 74th best selling brand-name drug in by retail dollars in the United States in 2006.

Serious skin reactions have been reported in children and adults in association with Trileptal use. In the event a skin reaction should occur while taking Trileptal patients should immediately consult with their health care provider. Common side effects reported with Trileptal use include dizziness and drowsiness.




(Epilepsy :: FDA approves first generic anticonvulsant drug Trileptal published at SpiritIndia on Wednesday, October 10, 2007)



Epilepsy

Search more information on Epilepsy, Epilepsy books

Recently posted related articles on Epilepsy :

  1. Epilepsy :: Reports of seizure frequency may be inaccurate in patients with focal epilepsy
  2. Epilepsy :: Once-a-day epilepsy drug is effective for partial seizures
  3. Epilepsy :: FDA approves first generic anticonvulsant drug Trileptal
  4. Epilepsy :: Research shows how genetic mutation causes epilepsy in infants
  5. Epilepsy :: GSK's Lamictal extended-release tablets for epilepsy
  6. Epilepsy :: Study of New Epilepsy Treatment Underway at URMC
  7. Epilepsy :: Implantable device designed to detect, stop seizures under study at MCG
  8. Epilepsy :: Ovation further advances development pipeline with new phase III epilepsy study
  9. Epilepsy :: Experiencing auras? You may be a good candidate for epilepsy surgery
  10. Epilepsy :: Miniature implanted devices could treat epilepsy, glaucoma

Most related articles:

- Epilepsy :: FDA approves first generic anticonvulsant drug Trileptal
- Bacterial Vaginosis :: FDA Approves First Generic Metronidazole - 9.4
- Blood Pressure :: FDA approves first generic versions of Coreg to treat high blood pressure - 8.9
- HIV :: FDA approves generic zidovudine oral solution - 8.8
- Chemotherapy :: FDA Approves First Generic Ondansetron Injection - 8.5
- Epilepsy :: New indication for Topamax for adults and children with epilepsy - 8.5
- Epilepsy :: Older epilepsy drugs have birth defect risk - 8
- Chemotherapy :: FDA approves Mylan's Ondansetron Orally Disintegrating Tablets - 8
- Onychomycosis :: FDA approves Lamisil for nail fungus infection, onychomycosis - 7.9
- Epilepsy :: Ovation further advances development pipeline with new phase III epilepsy study - 7.9


Epilepsy - recent related articles/news stories:

- Sabril to treat spasms in infants and epileptic seizures approved in US
- Epilepsy drug valproate during pregnancy lowers child's IQ
- Epilepsy drug topiramate during pregnancy raises birth defects risk
- Oxcarbazepine doesn't help prevent migraine after all
- Suicidal thoughts and behaviours from epilepsy drugs, alerts Medsafe

»»   Obesity :: The thin stay thin while the fat are getting fatter
««   Prostate Cancer :: Prostate cancer more likely to return in blacks than whites






Tools
Daily calorie need
Homeo tips
Homeo softwares
Associations
NHMC Alumni
IFH
PHS
Vital Informer
Articles & news
Education
Homeo articles
Homeopathy cases
Homeopathic Remedies
You
Authors
Submit article
Your account
Testimonials
About
About us
Advertisers
Advertising
Linking us
Disclaimer
Privacy policy

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com